The research of Alexander Ljubimov, PhD, focuses on gene therapy for diabetic corneal stem cells, generation of corneal epithelium from iPSC for limbal stem cell deficiency therapy, inhibition of protein kinase CK2 to block pathological retinal angiogenesis and tumor growth, miRNA in normal and diabetic cornea, and targeted nanodrugs for cancer.

View NIH Biographical Sketch

• Master's: Lomonosov Moscow State University, 1974
• Doctorate: N.N. Blokhin Russian Cancer Research Center, 1979
• Post Doctorate: International Agency for Research on Cancer, 1983

View CV

• Cancer Institute (Samuel Oschin Comprehensive Cancer Institute)
• Department of Surgery
• Biomedical Sciences
• Cancer
• Neurosurgery
• Regenerative Medicine Institute (Board of Governors Regenerative Medicine Institute)